Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico

Introduction: Enteropathogenic bacteria isolated in Mexico City have shown a high rate of resistance to different antibiotics, with the exception of rifaximin (RIF). RIF is a nonabsorbable antibiotic that reaches high fecal concentrations (â 8,000 μg/g). Susceptibility to antimicrobials can vary i...

Full description

Bibliographic Details
Main Authors: O. Novoa-Farias, A.C. Frati-Munari, M.A. Peredo, S. Flores-Juárez, O. Novoa-García, J. Galicia-Tapia, C.E. Romero-Carpio
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:Revista de Gastroenterología de México (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2255534X17300270
id doaj-85f8630cbdf044d4b1481b2bebcdabf1
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author O. Novoa-Farias
A.C. Frati-Munari
M.A. Peredo
S. Flores-Juárez
O. Novoa-García
J. Galicia-Tapia
C.E. Romero-Carpio
spellingShingle O. Novoa-Farias
A.C. Frati-Munari
M.A. Peredo
S. Flores-Juárez
O. Novoa-García
J. Galicia-Tapia
C.E. Romero-Carpio
Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico
Revista de Gastroenterología de México (English Edition)
author_facet O. Novoa-Farias
A.C. Frati-Munari
M.A. Peredo
S. Flores-Juárez
O. Novoa-García
J. Galicia-Tapia
C.E. Romero-Carpio
author_sort O. Novoa-Farias
title Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico
title_short Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico
title_full Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico
title_fullStr Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico
title_full_unstemmed Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico
title_sort susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in southeast mexico
publisher Elsevier
series Revista de Gastroenterología de México (English Edition)
issn 2255-534X
publishDate 2017-07-01
description Introduction: Enteropathogenic bacteria isolated in Mexico City have shown a high rate of resistance to different antibiotics, with the exception of rifaximin (RIF). RIF is a nonabsorbable antibiotic that reaches high fecal concentrations (â 8,000 μg/g). Susceptibility to antimicrobials can vary in different geographic regions. Aim: To study the susceptibility to rifaximin and other antimicrobials of enteropathogenic bacteria isolated in patients with acute diarrhea in the southeastern region of Mexico. Material and methods: A total of 614 strains of bacteria isolated from patients with acute diarrhea from 4 cities in Southeast Mexico were analyzed. An antibiogram with the following antibiotics was created: ampicillin (AMP), trimethoprim/sulfamethoxazole (T-S), neomycin (NEO), furazolidone (FUR), ciprofloxacin (CIP), chloramphenicol (CHL), and fosfomycin (FOS), assessed through the agar diffusion method at the standard concentrations recommended by the Clinical and Laboratory Standards Institute (CLSI) and the American Society for Microbiology (ASM), and RIF, assessed through microdilution at 4 concentrations. Results: The bacteria were Escherichia coli (55%), as the majority, in all its pathogenic variants, Shigella (16.8%), Salmonella (15.3%), Aeromonas (7.8%), and less than 5% Campylobacter, Yersinia, Vibrio, and Plesiomonas. The accumulated overall susceptibility to RIF was 69.1, 90.8, 98.9, and 100% at concentrations of 100, 200, 400, and 800 μg/ml, respectively. Overall susceptibility to other antibiotics was FOS 82.8%, CHL 76.8%, CIP 73.9%, FUR 64%, T-S 58.7%, NEO 55.8%, and AMP 23.8%. Susceptibility to RIF at 400 and 800 μg was significantly greater than with the other antimicrobials (P<.001). Conclusions: The data of the present study were similar to those of a previous study carried out in Mexico City: susceptibility to RIF in > 98% of the bacterial strains and a high frequency of resistance to several common antimicrobials. Resumen: Antecedentes: Bacterias enteropatógenas aisladas en la Ciudad de México han mostrado una alta tasa de resistencia a diversos antibióticos, con excepción de la rifaximina (RIF). La RIF es un antibiótico no absorbible que alcanza altas concentraciones fecales (â 8,000 μg/g). La susceptibilidad a los antimicrobianos puede variar en distintas regiones geográficas. Objetivo: Investigar la susceptibilidad a rifaximina y otros antimicrobianos de bacterias enteropatógenas aisladas de pacientes con diarrea aguda en el sureste de México. Material y métodos: Se analizaron 614 cepas de bacterias aisladas de pacientes con diarrea aguda de 4 ciudades del sureste del México. Se realizó antibiograma con: ampicilina (AMP), trimetoprim/sulfametoxazol (T-S), neomicina (NEO), furazolidona (FUR), ciprofloxacino (CIP), cloranfenicol (CLO) y fosfomicina (FOS) por difusión en agar a las concentraciones estándar recomendadas por CLSI y ASM y RIF en 4 concentraciones por microdilución. Resultados: La mayoría de las bacterias fueron Escherichia coli (55%) en todas sus variantes patógenas, Shigella (16.8%), Salmonella (15.3%), Aeromonas (7.8%) y menos de 5% Campylobacter, Yersinia, Vibrio y Plesiomonas. La susceptibilidad global acumulada a RIF fue del 69.1, el 90.8, el 98.9 y el 100% a las concentraciones de 100, 200, 400 y 800 μg/ml, respectivamente. La susceptibilidad global a los otros antibióticos fue: FOS 82.8%, CLO 76.8%, CIP 73.9%, FUR 64%, T-S 58.7%, NEO 55.8% y AMP 23.8%. La susceptibilidad a RIF 400 y 800 μg fue significativamente mayor que con los otros antimicrobianos (p < 0.001). Conclusiones: Se encontraron datos similares a los de un estudio previo realizado en la Ciudad de México: susceptibilidad a RIF en > 98% de las cepas bacterianas y alta frecuencia de resistencia a varios antimicrobianos comunes. Keywords: Rifaximin, Bacterial resistance, Bacterial susceptibility, Southeast Mexico, Gastroenteritis, Acute diarrhea, Palabras clave: Rifaximina, Resistencia bacteriana, Susceptibilidad bacteriana, Sureste mexicano, Gastroenteritis, Diarrea aguda
url http://www.sciencedirect.com/science/article/pii/S2255534X17300270
work_keys_str_mv AT onovoafarias susceptibilitytorifaximinandotherantimicrobialsofbacteriaisolatedinpatientswithacutegastrointestinalinfectionsinsoutheastmexico
AT acfratimunari susceptibilitytorifaximinandotherantimicrobialsofbacteriaisolatedinpatientswithacutegastrointestinalinfectionsinsoutheastmexico
AT maperedo susceptibilitytorifaximinandotherantimicrobialsofbacteriaisolatedinpatientswithacutegastrointestinalinfectionsinsoutheastmexico
AT sfloresjuarez susceptibilitytorifaximinandotherantimicrobialsofbacteriaisolatedinpatientswithacutegastrointestinalinfectionsinsoutheastmexico
AT onovoagarcaa susceptibilitytorifaximinandotherantimicrobialsofbacteriaisolatedinpatientswithacutegastrointestinalinfectionsinsoutheastmexico
AT jgaliciatapia susceptibilitytorifaximinandotherantimicrobialsofbacteriaisolatedinpatientswithacutegastrointestinalinfectionsinsoutheastmexico
AT ceromerocarpio susceptibilitytorifaximinandotherantimicrobialsofbacteriaisolatedinpatientswithacutegastrointestinalinfectionsinsoutheastmexico
_version_ 1725568509150232576
spelling doaj-85f8630cbdf044d4b1481b2bebcdabf12020-11-24T23:22:20ZengElsevierRevista de Gastroenterología de México (English Edition)2255-534X2017-07-01823226233Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast MexicoO. Novoa-Farias0A.C. Frati-Munari1M.A. Peredo2S. Flores-Juárez3O. Novoa-García4J. Galicia-Tapia5C.E. Romero-Carpio6División de Microbiología Clínica, Unidad de Diagnóstico Microbiológico UDMSC, Mexico City, MexicoDepartamento de Medicina Interna, Hospital Médica Sur, Mexico City, Mexico; Corresponding author. Alfa Wasserman S.A. de C.V., Av. Insurgentes Sur 2453-803, Col. Tizapán San Ãngel, Del. Ãlvaro Obregón, Mexico City, Mexico. Tel.: 54814707.Alliance for the prudent use of antibiotics (APUA), Chapter México, Mexico City, MexicoAlliance for the prudent use of antibiotics (APUA), Chapter México, Mexico City, MexicoDivisión de Microbiología Clínica, Unidad de Diagnóstico Microbiológico UDMSC, Mexico City, MexicoDivisión de Microbiología Clínica, Unidad de Diagnóstico Microbiológico UDMSC, Mexico City, MexicoDivisión de Microbiología Clínica, Unidad de Diagnóstico Microbiológico UDMSC, Mexico City, MexicoIntroduction: Enteropathogenic bacteria isolated in Mexico City have shown a high rate of resistance to different antibiotics, with the exception of rifaximin (RIF). RIF is a nonabsorbable antibiotic that reaches high fecal concentrations (â 8,000 μg/g). Susceptibility to antimicrobials can vary in different geographic regions. Aim: To study the susceptibility to rifaximin and other antimicrobials of enteropathogenic bacteria isolated in patients with acute diarrhea in the southeastern region of Mexico. Material and methods: A total of 614 strains of bacteria isolated from patients with acute diarrhea from 4 cities in Southeast Mexico were analyzed. An antibiogram with the following antibiotics was created: ampicillin (AMP), trimethoprim/sulfamethoxazole (T-S), neomycin (NEO), furazolidone (FUR), ciprofloxacin (CIP), chloramphenicol (CHL), and fosfomycin (FOS), assessed through the agar diffusion method at the standard concentrations recommended by the Clinical and Laboratory Standards Institute (CLSI) and the American Society for Microbiology (ASM), and RIF, assessed through microdilution at 4 concentrations. Results: The bacteria were Escherichia coli (55%), as the majority, in all its pathogenic variants, Shigella (16.8%), Salmonella (15.3%), Aeromonas (7.8%), and less than 5% Campylobacter, Yersinia, Vibrio, and Plesiomonas. The accumulated overall susceptibility to RIF was 69.1, 90.8, 98.9, and 100% at concentrations of 100, 200, 400, and 800 μg/ml, respectively. Overall susceptibility to other antibiotics was FOS 82.8%, CHL 76.8%, CIP 73.9%, FUR 64%, T-S 58.7%, NEO 55.8%, and AMP 23.8%. Susceptibility to RIF at 400 and 800 μg was significantly greater than with the other antimicrobials (P<.001). Conclusions: The data of the present study were similar to those of a previous study carried out in Mexico City: susceptibility to RIF in > 98% of the bacterial strains and a high frequency of resistance to several common antimicrobials. Resumen: Antecedentes: Bacterias enteropatógenas aisladas en la Ciudad de México han mostrado una alta tasa de resistencia a diversos antibióticos, con excepción de la rifaximina (RIF). La RIF es un antibiótico no absorbible que alcanza altas concentraciones fecales (â 8,000 μg/g). La susceptibilidad a los antimicrobianos puede variar en distintas regiones geográficas. Objetivo: Investigar la susceptibilidad a rifaximina y otros antimicrobianos de bacterias enteropatógenas aisladas de pacientes con diarrea aguda en el sureste de México. Material y métodos: Se analizaron 614 cepas de bacterias aisladas de pacientes con diarrea aguda de 4 ciudades del sureste del México. Se realizó antibiograma con: ampicilina (AMP), trimetoprim/sulfametoxazol (T-S), neomicina (NEO), furazolidona (FUR), ciprofloxacino (CIP), cloranfenicol (CLO) y fosfomicina (FOS) por difusión en agar a las concentraciones estándar recomendadas por CLSI y ASM y RIF en 4 concentraciones por microdilución. Resultados: La mayoría de las bacterias fueron Escherichia coli (55%) en todas sus variantes patógenas, Shigella (16.8%), Salmonella (15.3%), Aeromonas (7.8%) y menos de 5% Campylobacter, Yersinia, Vibrio y Plesiomonas. La susceptibilidad global acumulada a RIF fue del 69.1, el 90.8, el 98.9 y el 100% a las concentraciones de 100, 200, 400 y 800 μg/ml, respectivamente. La susceptibilidad global a los otros antibióticos fue: FOS 82.8%, CLO 76.8%, CIP 73.9%, FUR 64%, T-S 58.7%, NEO 55.8% y AMP 23.8%. La susceptibilidad a RIF 400 y 800 μg fue significativamente mayor que con los otros antimicrobianos (p < 0.001). Conclusiones: Se encontraron datos similares a los de un estudio previo realizado en la Ciudad de México: susceptibilidad a RIF en > 98% de las cepas bacterianas y alta frecuencia de resistencia a varios antimicrobianos comunes. Keywords: Rifaximin, Bacterial resistance, Bacterial susceptibility, Southeast Mexico, Gastroenteritis, Acute diarrhea, Palabras clave: Rifaximina, Resistencia bacteriana, Susceptibilidad bacteriana, Sureste mexicano, Gastroenteritis, Diarrea agudahttp://www.sciencedirect.com/science/article/pii/S2255534X17300270